Enadenotucirev Uses, Dosage, Side Effects and more
Enadenotucirev is under investigation in clinical trial NCT02636036 (Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Enadenotucirev |
| Generic | Enadenotucirev |
| Enadenotucirev Other Names | Enadenotucirev |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
